Morgan Stanley Tela Bio, Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Tela Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 17,822 shares of TELA stock, worth $43,663. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,822
Previous 2,220
702.79%
Holding current value
$43,663
Previous $5,000
960.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding TELA
# of Institutions
52Shares Held
27.4MCall Options Held
754KPut Options Held
300-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$10.1 Million2.87% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.68MShares$9.02 Million0.56% of portfolio
-
Silverarc Capital Management, LLC3.07MShares$7.51 Million2.23% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.66MShares$6.52 Million3.26% of portfolio
-
Stonepine Capital Management, LLC Bend, OR2.35MShares$5.77 Million5.74% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $46.9M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...